Noa Therapeutics
PrivateLast Round
Pre Seed
Mar 7, 2024
Total Funding Raised
$1.64M
Company Overview
Noa Therapeutics operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was a Pre Seed round in March 2024.
Noa Therapeutics is a biotechnology company that develops novel trimodal small molecule therapeutics to address complex inflammatory barrier diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Noa Therapeutics Comparables
Compare Noa Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Athos Therapeutics | 81% | |
| Equillium Inc. | 71% | |
| Edesa Biotech Inc | 69% |
For institutional investors. Book with your work email.
Noa Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Noa Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Angel One Network | Pre Seed |
| Golden Triangle Angel Network | Pre Seed |
| Archangel Network | Pre Seed |
| NorthSpring Capital Partners | Pre Seed |
| University of Calgary | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 5, 2026
Monthly visitors grew 513% MoM to 1.8K.
- May 12, 2025
Grew 50% QoQ from 8 to 12 employees.
For institutional investors. Book with your work email.
Noa Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Noa Therapeutics's valuation, stock price, and market status.
Is Noa Therapeutics a public or private company?
Noa Therapeutics is a private company.
What is the current stock price of Noa Therapeutics?
Noa Therapeutics is a private company, so its shares have no public market price. Caplight tracks Noa Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Noa Therapeutics worth (valuation)?
Valuation information for Noa Therapeutics is not publicly available.
Can I buy Noa Therapeutics stock?
Noa Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Noa Therapeutics's last funding round?
Noa Therapeutics's most recent funding round was Pre Seed on March 7, 2024.
Who are the main investors in Noa Therapeutics?
Key investors in Noa Therapeutics include University of Calgary.
Will Noa Therapeutics IPO soon?
No public IPO plans have been announced for Noa Therapeutics.
How can I track Noa Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Noa Therapeutics's shares on secondary markets.